[go: up one dir, main page]

ES2376095B1 - Pellets entéricos de duloxetina. - Google Patents

Pellets entéricos de duloxetina. Download PDF

Info

Publication number
ES2376095B1
ES2376095B1 ES201190024A ES201190024A ES2376095B1 ES 2376095 B1 ES2376095 B1 ES 2376095B1 ES 201190024 A ES201190024 A ES 201190024A ES 201190024 A ES201190024 A ES 201190024A ES 2376095 B1 ES2376095 B1 ES 2376095B1
Authority
ES
Spain
Prior art keywords
duloxetine
intermediate layer
layer
enteric
page
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES201190024A
Other languages
English (en)
Spanish (es)
Other versions
ES2376095A1 (es
Inventor
Gemma Casadevall Pujals
Montserrat GARCÍA ROVIRA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Esteve Pharmaceuticals SA
Original Assignee
Laboratorios del Dr Esteve SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios del Dr Esteve SA filed Critical Laboratorios del Dr Esteve SA
Publication of ES2376095A1 publication Critical patent/ES2376095A1/es
Application granted granted Critical
Publication of ES2376095B1 publication Critical patent/ES2376095B1/es
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
ES201190024A 2008-10-02 2009-10-02 Pellets entéricos de duloxetina. Expired - Fee Related ES2376095B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08380282 2008-10-02

Publications (2)

Publication Number Publication Date
ES2376095A1 ES2376095A1 (es) 2012-03-09
ES2376095B1 true ES2376095B1 (es) 2013-01-24

Family

ID=40325771

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201190024A Expired - Fee Related ES2376095B1 (es) 2008-10-02 2009-10-02 Pellets entéricos de duloxetina.

Country Status (2)

Country Link
ES (1) ES2376095B1 (fr)
WO (1) WO2010037849A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2377525A1 (fr) * 2010-03-26 2011-10-19 Laboratorios del Dr. Esteve S.A. Granulés entériques à la duloxétine
PL224543B1 (pl) 2013-08-21 2017-01-31 Pabianickie Zakłady Farm Polfa Spółka Akcyjna Dojelitowa tabletka duloksetyny
RS61368B1 (sr) * 2018-09-27 2021-02-26 Inibsa Ginecologia S A Postupak za pripremu višejediničnog oralnog doznog oblika sa modifikovanim oslobađanjem doksilamin sukcinata i piridoksin hidrohlorida

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508276A (en) * 1994-07-18 1996-04-16 Eli Lilly And Company Duloxetine enteric pellets
US5776969A (en) * 1997-02-27 1998-07-07 Eli Lilly And Company Treatment of sleep disorders
EP1424079A1 (fr) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combinaison d'un agoniste du beta-3-récepteur et d'un inhibiteur de recaptage de sérotonine et/ou norépinéphrine
US20060165776A1 (en) * 2005-08-31 2006-07-27 Ramesh Sesha Antidepressant oral pharmaceutical compositions
BRPI0711606A2 (pt) * 2006-05-22 2012-02-14 Teva Pharma formulações de hidrocloreto de duloxetina de liberação retardada
WO2008020286A2 (fr) * 2006-08-14 2008-02-21 Torrent Pharmaceuticals Limited Compositions pharmaceutiques de duloxétine
EP2099492B1 (fr) * 2006-12-27 2013-06-05 LEK Pharmaceuticals d.d. Composition a base de duloxetine
US20080226711A1 (en) * 2007-03-12 2008-09-18 Torrent Pharmaceuticals Ltd. Pharmaceutical compositions of duloxetine
WO2008129501A2 (fr) * 2007-04-20 2008-10-30 Wockhardt Research Centre Compositions pharmaceutiques de duloxetine
WO2009066181A2 (fr) * 2007-07-09 2009-05-28 Combino Pharm, S.L. Pastilles de chlorhydrate de duloxétine pour administration orale à libération retardée
WO2009087657A2 (fr) * 2007-11-03 2009-07-16 Alkem Laboratories Ltd. Composition pharmaceutique stable de duloxétine et son procédé de préparation

Also Published As

Publication number Publication date
WO2010037849A1 (fr) 2010-04-08
ES2376095A1 (es) 2012-03-09

Similar Documents

Publication Publication Date Title
ES2667944T3 (es) Gránulos y comprimidos orodispersables que contienen oxicodona
EP3154523B1 (fr) Formulation pour administration par voie orale contenant de la mésalazine
RU2428176C2 (ru) Системы доставки лекарственного средства, содержащие слабоосновные лекарственные средства и органические кислоты
BRPI0711606A2 (pt) formulações de hidrocloreto de duloxetina de liberação retardada
ES2304349T3 (es) Formulacion de benzimidazol estable.
JP6796132B2 (ja) 液体剤形中の薬学的活性化合物放出性多層微小粒子
HK1214182A1 (zh) 采用含有中性乙烯基聚合物和赋形剂的包衣的具有耐乙醇影响的控释药物组合物
ES2667402T3 (es) Composición farmacéutica de omeprazol
ES2560052T5 (es) Comprimido bicapa que comprende clorhidrato de benazepril y pimobendan
AU2008347949A1 (en) Stabilized sustained release composition of bupropion hydrochloride and process for preparing the same
EP3137057B1 (fr) Compositions de metformine liquides à libération prolongée
US11504345B2 (en) Extended release liquid compositions of metformin
ES2303238T3 (es) Preparacion granulada de liberacion lenta que contiene una droga con estructura de amina con base en particulas con una capa de recubrimiento y el correspondiente metodo de produccion.
CA2637444A1 (fr) Composition pharmaceutique de tolterodine enrobee ou sel de celle-ci presentant une dissolution rapide dans des conditions acides et une dissolution lente a des valeurs de ph pluselevees
CN105073100A (zh) 坦索罗辛或其盐的药物组合物
ES2726049T3 (es) Capas de separación para preparaciones farmacéuticas para impedir interacciones entre sustancias farmacológicas y adyuvantes farmacéuticos-tecnológicos
JP2013510128A (ja) 固形製剤
ES2417330T3 (es) Minicomprimidos farmacéuticos para la liberación sostenida de acetato de flecainida
ES2376095B1 (es) Pellets entéricos de duloxetina.
JPS58116414A (ja) ニカルジピン持続性製剤用球形顆粒およびその製造法
AU2017339246B2 (en) Delayed release pharmaceutical composition of pantoprazole and process for preparation thereof
US20080118554A1 (en) Pharmaceutical compositions comprising a combination of piperidinoalkanol and decongestant
EP2345408A2 (fr) Formulations de médicament labiles acides
ES2377473B1 (es) Pellets entéricos de duloxetina.
TR201801650T1 (tr) Kontrollü salim propi̇veri̇n formülasyonlari

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2376095

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20130124

FD2A Announcement of lapse in spain

Effective date: 20210915